TotalMarketCap

Silo Pharma

SILONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.566 M

$1.35 +1.36%

Close of 6 Nov 2026

As of 6 Nov 2026, Silo Pharma (SILO) has a market capitalization of $2.57M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$72.1K

#3577 by revenue

Earnings

-$4.23M

Loss-making

Shares outstanding

1,588,250

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #476Decoy TherapeuticsDCOY$2.70M
  2. #477PRF TechnologiesPRFX$2.64M
  3. #478Silo PharmaSILO$2.57M
  4. #479Galmed PharmaceuticalsEOCN$2.55M
  5. #480HCW BiologicsHCWB$2.30M

What if Silo Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$14,836,137

Per share 11,005,220× higher

Bitcoin $1.53T

$802,757.53

Per share 595,473× higher

Apple $5.02T

$2,635,378

Per share 1,954,883× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Silo Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.